Milestone Event. Milestone Payment
Milestone Event. The Milestone Event having occurred;
Milestone Event. [*]+ [*]+ [*] *+ Payment Amount $ [*] $ [*] $ [*] [*] $ [*] [*] $ [*] [*]* $ [*] * If [*] is [*] for the [*], but Portola decides [*] in [*] or [*], then the milestone shall be [*] the [*] for such [*] in the [*]. + Each milestone set forth above is intended to be paid only once. Additionally, each such amount shall become due upon the occurrence of the event specified, except as follows: For the purpose of this paragraph, [*], and [*], because each of such [*] the other [*] whether it is [*] or [*] that is [*]. If Portola first achieves any of [*] before achieving the [*], then upon either the next achievement of such milestone [*], whichever first occurs, the amount due upon achievement of the [*] shall become due. For example, if [*] for [*], and [*] for [*], then within [*] after [*] Portola shall pay to Millennium [*] and within [*] after [*] Portola shall pay to Millennium [*]. In no event shall Portola owe Millennium more than a total of $35 million pursuant to this Section 3.2.
Milestone Event. Worldwide Cumulative Net Sales of a Niclosamide Product equal to or greater than: Milestone Payment $500 Million $ 9.0 million $1 Billion $ 13.5 million $3 Billion $ 36.0 million $5 Billion $ 72.0 million
Milestone Event. The Milestone Event and corresponding Milestone Payment and Equity Percentages are as follows: Milestone Event Milestone Payment* Equity Percentage FDA IND Allowance for a Therapeutic Product $ 2,300,000 100 % Notes to Table: * All amounts in US dollars.
Milestone Event. Option Shares 1) Reaching break-even for a calendar quarter 1,000,000
Milestone Event. [***] For the avoidance of doubt, the Parties agree that all payments under this Section 6.2.2 are payable only once.
Milestone Event. Subject to the remainder of this Section 5.1, Licensee shall pay to Licensor a one-time, non-refundable development milestone payment of Twenty Five Million Dollars ($25,000,000) upon the first MAA approval for a BION-1301 Licensed Product by the NMPA (the “BION-1301 Approval Milestone”). The BION-1301 Approval Milestone shall be due and payable (i) irrespective of whether such milestone event is achieved by Licensee, its Affiliates or sublicensee and (ii) only if the milestone event is achieved in mainland China. The BION-1301 Approval Milestone is payable only once, regardless of how many times such milestone event is achieved and/or the number of BION-1301 Licensed Products that achieve such milestone event.
Milestone Event. The Transfer Payment shall be paid to SGI by MLFC, subject to satisfaction of the provisions of Section 13.3 below, upon the occurrence of the earlier to occur of either of the following (each, a "Milestone Event"):
Milestone Event. Payment Amount (in millions)
